Healthcare provider profile · identity verified

William M Borgos, MD

Family Practice · GLENS FALLS, NY · NPI 1932113669

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	357	94
Omeprazole	Omeprazole	308	94
Amlodipine Besylate	Amlodipine Besylate	286	83
Lisinopril	Lisinopril	280	75
Levothyroxine Sodium	Levothyroxine Sodium	274	66
Rosuvastatin Calcium	Rosuvastatin Calcium	223	59
Tamsulosin Hcl	Tamsulosin Hcl	196	55
Losartan Potassium	Losartan Potassium	193	60
Metoprolol Succinate	Metoprolol Succinate	155	41
Gabapentin	Gabapentin	141	34
Metformin Hcl	Metformin Hcl	126	30
Simvastatin	Simvastatin	124	34
Hydrochlorothiazide	Hydrochlorothiazide	123	35
Escitalopram Oxalate	Escitalopram Oxalate	117	25
Allopurinol	Allopurinol	111	25
Alprazolam	Alprazolam	84	21
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	82	15
Furosemide	Furosemide	79	26
Albuterol Sulfate Hfa	Albuterol Sulfate	77	31
Eliquis	Apixaban	76	15
Fluticasone Propionate	Fluticasone Propionate	76	31
Oxycodone Hcl	Oxycodone Hcl	75	suppressed
Trulicity	Dulaglutide	75	11
Finasteride	Finasteride	71	18
Tramadol Hcl	Tramadol Hcl	71	12
Metformin Hcl Er	Metformin Hcl	69	19
Potassium Chloride	Potassium Chloride	64	17
Metoprolol Tartrate	Metoprolol Tartrate	60	13
Pantoprazole Sodium	Pantoprazole Sodium	59	17
Trazodone Hcl	Trazodone Hcl	59	17
Venlafaxine Hcl Er	Venlafaxine Hcl	59	suppressed
Ozempic	Semaglutide	56	14
Duloxetine Hcl	Duloxetine Hcl	53	14
Mirtazapine	Mirtazapine	53	14
Sertraline Hcl	Sertraline Hcl	51	15
Prednisone	Prednisone	49	31
Bupropion Xl	Bupropion Hcl	48	suppressed
Montelukast Sodium	Montelukast Sodium	46	14
Clopidogrel	Clopidogrel Bisulfate	45	14
Famotidine	Famotidine	42	11
Olmesartan Medoxomil	Olmesartan Medoxomil	41	12
Synthroid	Levothyroxine Sodium	41	11
Jardiance	Empagliflozin	40	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	38	suppressed
Citalopram Hbr	Citalopram Hydrobromide	37	suppressed
Lorazepam	Lorazepam	37	suppressed
Midodrine Hcl	Midodrine Hcl	35	suppressed
Celecoxib	Celecoxib	33	11
Clonazepam	Clonazepam	33	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	33	suppressed
Mounjaro	Tirzepatide	32	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	32	suppressed
Alendronate Sodium	Alendronate Sodium	30	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	30	suppressed
Morphine Sulfate Er	Morphine Sulfate	30	suppressed
Spironolactone	Spironolactone	29	suppressed
Propranolol Hcl	Propranolol Hcl	28	suppressed
Valacyclovir	Valacyclovir Hcl	28	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	27	suppressed
Diazepam	Diazepam	26	suppressed
Donepezil Hcl	Donepezil Hcl	26	suppressed
Lurasidone Hcl	Lurasidone Hcl	26	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	25	16
Ondansetron Hcl	Ondansetron Hcl	25	suppressed
Baclofen	Baclofen	24	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	24	suppressed
Paroxetine Hcl	Paroxetine Hcl	24	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	23	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	23	17
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	22	suppressed
Tradjenta	Linagliptin	20	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	20	suppressed
Glimepiride	Glimepiride	19	suppressed
Olanzapine	Olanzapine	19	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	18	suppressed
Naproxen	Naproxen	18	suppressed
Pravastatin Sodium	Pravastatin Sodium	18	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	17	suppressed
Nifedipine Er	Nifedipine	17	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	17	suppressed
Ramipril	Ramipril	17	suppressed
Amiodarone Hcl	Amiodarone Hcl	16	suppressed
Atenolol	Atenolol	16	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	16	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	16	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	16	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	16	suppressed
Novolog Flexpen	Insulin Aspart	16	suppressed
Azelastine Hcl	Azelastine Hcl	15	suppressed
Irbesartan	Irbesartan	15	suppressed
Meloxicam	Meloxicam	15	11
Ropinirole Hcl	Ropinirole Hcl	15	suppressed
Nadolol	Nadolol	14	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	14	suppressed
Silodosin	Silodosin	14	suppressed
Testosterone	Testosterone	14	suppressed
Bupropion Hcl	Bupropion Hcl	13	suppressed
Carvedilol	Carvedilol	13	suppressed
Enalapril Maleate	Enalapril Maleate	13	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	13	suppressed
Lithium Carbonate	Lithium Carbonate	13	suppressed
Lubiprostone	Lubiprostone	13	suppressed
Rexulti	Brexpiprazole	13	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	13	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	12	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	12	11
Clotrimazole	Clotrimazole	12	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	12	suppressed
Epinephrine	Epinephrine	12	11
Glipizide	Glipizide	12	suppressed
Wegovy	Semaglutide	12	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	11	suppressed
Azithromycin	Azithromycin	11	11
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	11	suppressed
Diclofenac Sodium	Diclofenac Sodium	11	suppressed
Ipratropium Bromide	Ipratropium Bromide	11	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	11	suppressed
Topiramate	Topiramate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error